News

A new drug dubbed ‘flysky’ is spreading through the US, with officials warning it can kill. The drug is being sold throughout ...
"The latest expansion of the program is at the Blue Springs Chamber of Commerce on Main Street, where Jackson County Public ...
Kratom manufacturers caution that the supplement isn't always safe in the unregulated market. Lawmakers are now seeking to ...
The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse ...
Cambodian Defense Ministry Spokesperson Maly Socheata confirmed that the two wounded soldiers had been handed over at a ...
The U.S. Food and Drug Administration is taking significant steps in the ongoing fight against the Opioid Crisis.
Presentations to include efficacy, safety and opioid use reduction data in two different surgery models as well as pharmacokinetics data  PITTSBURGH, Aug.
The FDA is recommending that certain products containing 7-hydroxymitragynine be subject to the Controlled Substances Act.
The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.
The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ labels warning ...